Amedeo Smart

Free Medical Literature Service

 

Amedeo

Hypertension
  Free Subscription

Articles published in
Am Heart J
    April 2024
  1. DAUBERT MA, Stebbins A, Peragallo-Urrutia R, Chiswell K, et al
    Early Postpartum Blood Pressure Screening is Associated with Increased Detection of Cardiovascular Risk Factors in Women with Hypertensive Disorders of Pregnancy.
    Am Heart J. 2024 Apr 4:S0002-8703(24)00076-0. doi: 10.1016/j.ahj.2024.
    >> Share

  2. ZHANG H, Huo X, Ren L, Lu J, et al
    Design and rationale of the Comprehensive intelligent Hypertension managEment SyStem (CHESS) evaluation study: a cluster randomized controlled trial for hypertension management in primary care.
    Am Heart J. 2024 Apr 2:S0002-8703(24)00079-6. doi: 10.1016/j.ahj.2024.
    >> Share

    March 2024
  3. MILLER HE, Tierney S, Stefanick ML, Mayo JA, et al
    Vascular health years after a hypertensive disorder of pregnancy: The EPOCH Study.
    Am Heart J. 2024 Mar 12:S0002-8703(24)00055-3. doi: 10.1016/j.ahj.2024.
    >> Share

  4. HAMO CE, Schlamp F, Drenkova K, Jindal M, et al
    Burden of cardiometabolic risk factors and vascular health.
    Am Heart J. 2024;269:201-204.
    >> Share

    February 2024
  5. MEHDIPOOR G, Redfors B, Chen S, Gkargkoulas F, et al
    Hypertension, Microvascular Obstruction and Infarct Size in Patients with STEMI Undergoing PCI: Pooled Analysis from 7 Cardiac Magnetic Resonance Imaging Studies.
    Am Heart J. 2024 Feb 29:S0002-8703(24)00050-4. doi: 10.1016/j.ahj.2024.
    >> Share

    December 2023
  6. CHITTURI KR, Haberman D, Wermers JP, Waksman R, et al
    Overview of the 2023 FDA Circulatory System Devices Advisory Panel Meeting on the Symplicity Spyral Renal Denervation System.
    Am Heart J. 2023 Dec 19:S0002-8703(23)00350-2. doi: 10.1016/j.ahj.2023.
    >> Share

    November 2023
  7. KIM M, Choi JH, Kim HK, Kim HL, et al
    Effects of Intensive Blood Pressure Control on Left Ventricular Hypertrophy in Aortic Valve Disease.
    Am Heart J. 2023 Nov 23:S0002-8703(23)00321-6. doi: 10.1016/j.ahj.2023.
    >> Share

  8. HAFF N, Sreedhara SK, Wood W, Yom-Tov E, et al
    Testing interventions to reduce clinical inertia in the treatment of hypertension: rationale and design of a pragmatic randomized controlled trial.
    Am Heart J. 2023 Nov 13:S0002-8703(23)00313-7. doi: 10.1016/j.ahj.2023.
    >> Share

  9. GNANENTHIRAN SR, Tan I, Atkins ER, Avolio A, et al
    Transforming blood pressure control in primary care through a novel remote decision support strategy based on wearable blood pressure monitoring: The NEXTGEN-BP randomized trial protocol.
    Am Heart J. 2023;265:50-58.
    >> Share

    June 2023
  10. ZHAO X, Chen Y, Yang G, Li X, et al
    Initial treatment with a single capsule containing half-dose quadruple therapy versus standard-dose dual therapy in hypertensive patients (QUADUAL): Study protocol for a randomized, blinded, crossover trial.
    Am Heart J. 2023 Jun 3:S0002-8703(23)00142-4. doi: 10.1016/j.ahj.2023.
    >> Share

    April 2023
  11. DA FONSECA SF, Pinho Ribeiro AL, Rodrigues Cimini CC, de Castro Soares TB, et al
    Scale up of implementation of a multidimensional intervention to enhance hypertension and diabetes care at the primary care setting: a protocol for a cluster-randomized study in Brazil.
    Am Heart J. 2023 Apr 10:S0002-8703(23)00092-3. doi: 10.1016/j.ahj.2023.
    >> Share

  12. FU G, Zhou Z, Jian B, Huang S, et al
    Systolic blood pressure time in target range and long-term outcomes in patients with ischemic cardiomyopathy.
    Am Heart J. 2023;258:177-185.
    >> Share

  13. FANAROFF AC, Coratti S, Halaby R, Sanghavi M, et al
    Feasibility and outcomes from using a commitment device and text message reminders to increase adherence to time-restricted eating: A randomized trial.
    Am Heart J. 2023;258:85-95.
    >> Share

    January 2023
  14. WU Q, Ye Z, Zhou C, Liu M, et al
    A U-shaped association between dietary phosphorus intake and new-onset hypertension: A nationwide cohort study in China.
    Am Heart J. 2023 Jan 20:S0002-8703(23)00020-0. doi: 10.1016/j.ahj.2023.
    >> Share

  15. GREEN MD, Dalmage MR, Lusk JB, Kadhim EF, et al
    Public Reporting of Black Participation in Anti-Hypertensive Drug Clinical Trials.
    Am Heart J. 2023 Jan 11:S0002-8703(23)00001-7. doi: 10.1016/j.ahj.2023.
    >> Share

  16. LAUFFENBURGER JC, Khatib R, Siddiqi A, Albert MA, et al
    Reducing ethnic and racial disparities by improving undertreatment, control, and engagement in blood pressure management with health information technology (REDUCE-BP) hybrid effectiveness-implementation pragmatic trial: Rationale and design.
    Am Heart J. 2023;255:12-21.
    >> Share

    December 2022
  17. BENINCASA G, Napoli C, Loscalzo J, Maron BA, et al
    Pursuing Functional Biomarkers in Complex Disease: Focus on Pulmonary Arterial Hypertension.
    Am Heart J. 2022 Dec 21:S0002-8703(22)00330-1. doi: 10.1016/j.ahj.2022.
    >> Share

  18. LIU J, Wang B, Li Y, Yan X, et al
    Rationale and design of the Effects of intensive Systolic blood Pressure lowering treatment in reducing RIsk of vascular evenTs (ESPRIT): a multicenter open-label randomized controlled trial.
    Am Heart J. 2022 Dec 6:S0002-8703(22)00322-2. doi: 10.1016/j.ahj.2022.
    >> Share

    October 2022
  19. EGBE AC, Miranda WR, Jain CC, Connolly HM, et al
    On-Treatment Blood Pressure and Cardiovascular Mortality In Adults with Repaired Coarctation of Aorta.
    Am Heart J. 2022 Oct 8. pii: S0002-8703(22)00203.
    >> Share

    September 2022
  20. BALDRIDGE AS, Huffman MD, Lazar D, Abbas H, et al
    Efficacy and Safety of a Quadruple Ultra-low-dose Treatment for Hypertension (QUARTET USA): Rationale and Design for a Randomized Controlled Trial.
    Am Heart J. 2022 Sep 15. pii: S0002-8703(22)00189.
    >> Share

    August 2022
  21. WANG SY, Hanna JM, Gongal P, Onuma O, et al
    Choice of Antihypertensive Agent in Isolated Systolic Hypertension and Isolated Diastolic Hypertension: A Secondary Analysis of the ALLHAT Trial.
    Am Heart J. 2022 Aug 3. pii: S0002-8703(22)00157.
    >> Share

    July 2022
  22. SUZUKI Y, Kaneko H, Yano Y, Okada A, et al
    Glycemic status and the association of change in blood pressure with incident cardiovascular disease.
    Am Heart J. 2022 Jul 21. pii: S0002-8703(22)00148.
    >> Share

  23. MACEDO AVS, de Barros E Silva PGM, de Paula TC, Moll-Bernardes RJ, et al
    Discontinuing vs continuing ACEIs and ARBs in hospitalized patients with COVID-19 according to disease severity: Insights from the BRACE CORONA trial.
    Am Heart J. 2022;249:86-97.
    >> Share

    June 2022
  24. MAGANJA D, Trieu K, Reading M, Huang L, et al
    Protocol for a novel sodium and blood pressure reduction intervention targeting online grocery shoppers with hypertension - the SaltSwitch Online Grocery Shopping (OGS) randomised trial.
    Am Heart J. 2022 Jun 28. pii: S0002-8703(22)00131.
    >> Share

    May 2022
  25. HENDRIKS PM, van de Groep LD, Veen KM, van Thor MCJ, et al
    Prognostic value of brain natriuretic peptides in patients with pulmonary arterial hypertension: a systematic review and meta-analysis.
    Am Heart J. 2022 May 6. pii: S0002-8703(22)00093.
    >> Share

  26. SHAH NP, Clare RM, Chiswell K, Navar AM, et al
    Trends of blood pressure control in the U.S. during the COVID-19 pandemic.
    Am Heart J. 2022;247:15-23.
    >> Share

    April 2022
  27. KAZE AD, Gao X, Musani SK, Bidulescu A, et al
    Association of plasma endothelin-1 with blood pressure progression among Blacks: The Jackson Heart Study.
    Am Heart J. 2022;246:144-151.
    >> Share

    October 2021
  28. ZHEUTLIN AR, Derington CG, King JB, Berchie RO, et al
    Factors Associated with Antihypertensive Monotherapy Among US Adults with Treated Hypertension and Uncontrolled Blood Pressure Overall and by Race/Ethnicity, NHANES 2013-2018.
    Am Heart J. 2021 Oct 15. pii: S0002-8703(21)00436.
    >> Share

  29. WEAVER AM, McGuinn LA, Neas L, Devlin RB, et al
    Associations between neighborhood socioeconomic cluster and hypertension, diabetes, myocardial infarction, and coronary artery disease within a cohort of cardiac catheterization patients.
    Am Heart J. 2021 Oct 2. pii: S0002-8703(21)00243.
    >> Share

  30. SANDHU AT, Kohsaka S, Lin S, Woo CY, et al
    Renin-angiotensin-aldosterone system inhibitors and SARS-CoV-2 infection: an analysis from the veteran's affairs healthcare system.
    Am Heart J. 2021;240:46-57.
    >> Share

    July 2021
  31. EGBE AC, Miranda WR, Connolly HM, Borlaug BA, et al
    Coarctation of Aorta is Associated with Left Ventricular Stiffness, Left Atrial Dysfunction and Pulmonary Hypertension.
    Am Heart J. 2021 Jul 18. pii: S0002-8703(21)00184.
    >> Share

    May 2021
  32. MAHFOUD F, Weber M, Schmieder RE, Lobo MD, et al
    Catheter-based alcohol-mediated renal denervation for the treatment of uncontrolled hypertension: design of two sham-controlled, randomized, blinded trials in the absence (TARGET BP OFF-MED) and presence (TARGET BP I) of antihypertensive medications.
    Am Heart J. 2021 May 27. pii: S0002-8703(21)00144.
    >> Share

  33. STEVENS BR, Pepine CJ, Richards EM, Kim S, et al
    Depressive-hypertension: A proposed human endotype of brain/gut microbiome dysbiosis.
    Am Heart J. 2021 May 10:100540. doi: 10.1016/j.ahj.2021.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016